ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,434Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 49

$436K Total Retail Price of All Prescriptions

Rank: 10 out of 49

261 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 261 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 261 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,316 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 379 278 1 1
SIMVASTATIN 372 307 2 2
FUROSEMIDE 287 217 3 5
LISINOPRIL 265 197 4 3
METFORMIN HCL 207 155 5 10
METOPROLOL TARTRATE 166 127 6 11
ALLOPURINOL 159 127 7 21
METOPROLOL SUCCINATE 153 114 8 16
OMEPRAZOLE 153 105 8 4
HYDROCODONE-ACETAMINOPHEN 151 105 S3 10 7
AMLODIPINE BESYLATE 141 117 11 6
NEXIUM 130 77 12 27
GLIMEPIRIDE 114 106 13 49
AZITHROMYCIN 107 80 14 47
PANTOPRAZOLE SODIUM 103 72 15 32
ADVAIR DISKUS 102 88 16 28
CYMBALTA 101 33 17 33
ATORVASTATIN CALCIUM 95 89 18 13
LOSARTAN POTASSIUM 93 79 19 14
DEXILANT 93 53 19 67
CITALOPRAM HBR 92 60 21 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 81 22 34
WARFARIN SODIUM 88 88 23 8
CRESTOR 87 50 24 23
POTASSIUM CHLORIDE 87 74 24 9
GABAPENTIN 87 56 24 15
FLUTICASONE PROPIONATE 84 34 27 51
TAMSULOSIN HCL 79 52 28 25
CARVEDILOL 76 62 29 35
PROAIR HFA 70 38 30 58
LANTUS SOLOSTAR 69 41 31 112
ESCITALOPRAM OXALATE 69 51 31 52
CLOPIDOGREL 67 66 33 46
ATENOLOL 60 50 34 17
JANUMET 60 52 34 155
JANUVIA 59 46 36 44
ZOLPIDEM TARTRATE 57 53 37 19
SERTRALINE HCL 57 41 37 22
POLYETHYLENE GLYCOL 3350 53 34 39 78
LANTUS 51 43 40 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.